Search results
Mar 27, 2024 · Coronavirus disease 2019 (COVID-19) is an illness caused by the virus SARS-CoV-2. Learn more about the symptoms, risks and ways to protect yourself.
Nov 27, 2020 · This review has highlighted reported curative antiviral drugs and broad-spectrum antibiotics (both traditional and orthodox) used in the treatment of SARS-CoV-2; their chemistry, botanical sources, and active components as well as possible clinical trials and safety information.
- Joshua Adedeji Bolarin, Mercy Adaramodu Oluwatoyosi, Joshua Iseoluwa Orege, Emmanuel Ayodeji Ayeni, ...
- 10.1016/j.intimp.2020.107228
- 2021
- Int Immunopharmacol. 2021 Jan; 90: 107228.
Aug 18, 2023 · USA.gov. Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has had a catastrophic effect on the world, resulting in more than 6 million deaths worldwide.
- Marco Cascella, Michael Rajnik, Arturo Cuomo, Scott C. Dulebohn, Raffaela Di Napoli
- 2023/08/18
- 2020
COVID-19 Treatment Guidelines. About the Guidelines. Overview. Management. Therapies. Special Populations. Final Coronavirus Disease (COVID-19) Treatment Guidelines (February 29, 2024) SEE FINAL UPDATE. Credit NIAID-RML. Highlighted Sections. Nonhospitalized Adults: Therapeutic Management.
Dec 20, 2023 · As of January 2024, no biomedical intervention other than vaccines prevents disease after exposure to SARS-CoV-2. Previously, the FDA authorized the use of the anti-SARS-CoV-2 monoclonal antibody products bamlanivimab plus etesevimab and casirivimab plus imdevimab as post-exposure prophylaxis (PEP) in certain people at high risk of progression ...
Dec 20, 2023 · For diagnosing current SARS-CoV-2 infection, the CDC recommends using either a nucleic acid amplification test (NAAT) or an antigen test and using a specimen from the upper respiratory tract (e.g., nasal, nasopharyngeal). There may be a window period of up to 5 days after exposure before viral antigens or nucleic acids can be detected.
Oct 27, 2021 · Highly effective therapeutic agents directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19, are needed for these high-risk...
